تفاعل #156952

ord-5063db90618d4b29bb0545ea51a9bd58

معادلة التفاعل

I.NCCCNc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1
3-{4-[(3-aminopropyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydroiodide
NS(N)(=O)=O
sulfamide
NS(=O)(=O)NCCCNc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1
desired product
المردود 71.7%
NS(=O)(=O)NCCCNc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1
N-[3-({4-[4-(3-Bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl}amino)propyl]sulfamide
المردود 71.7%

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    تركيزThe reaction mixture was concentrated
  2. 2
    أخرىto give a crude residue
  3. 3
    أخرىThis material was purified by preparative LCMS

الإجراء التجريبي

A solution of 3-{4-[(3-aminopropyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydroiodide (150 mg, 0.28 mmol) and sulfamide (160 mg, 1.7 mmol) in pyridine (2.5 mL) was heated in a microwave at 130° C. for 10 min. The reaction mixture was concentrated to give a crude residue. This material was purified by preparative LCMS to give the desired product (96 mg, 71%) as a solid. LCMS for C13H14BrFN7O5S (M+H)+: m/z=478.0, 480.0. 1H NMR (400 MHz, DMSO-d6): δ 8.07 (dd, J=6.2, 2.5 Hz, 1 H), 7.73-7.69 (m, 1 H), 7.59 (dd, J=8.8, 8.6 Hz, 1 H), 6.57-6.51 (m, 4 H), 3.31-3.26 (m, 2 H), 2.92-2.87 (m, 2 H), 1.79-1.72 (m, 2 H).

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08822511B2uspto-grants-2014_09